Evobrutinib Terminated Phase 2 Trials for Systemic Lupus Erythematosus Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02975336A Phase II Study of M2951 in SLE